Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cal-5G is a branded generic nutritional supplement developed and marketed by the Indian pharmaceutical company Avogadro. Available in both tablet and syrup formulations, it is primarily designed to support bone health and address nutritional deficiencies. The "Cal" prefix indicates a focus on calcium supplementation, while the "5G" designation in the regional market typically refers to a combination of five specific herbal extracts (Ginseng, Ginkgo Biloba, Green Tea, Grape Seed, and Garlic) or a multi-ingredient blend of vitamins and minerals such as Vitamin D3, Magnesium, and Zinc. It is positioned within Avogadro's product range as an over-the-counter (OTC) or prescription-supported supplement for conditions like osteoporosis and calcium deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cal-5G.